DK514989A - Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler - Google Patents

Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler

Info

Publication number
DK514989A
DK514989A DK514989A DK514989A DK514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A
Authority
DK
Denmark
Prior art keywords
enolesters
oxindol
carboxamides
acyl
ethers
Prior art date
Application number
DK514989A
Other languages
English (en)
Other versions
DK514989D0 (da
Inventor
Thomas Charles Crawford
Lawrence Alan Reiter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK514989D0 publication Critical patent/DK514989D0/da
Publication of DK514989A publication Critical patent/DK514989A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK514989A 1988-10-18 1989-10-17 Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler DK514989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/003658 WO1990004393A1 (en) 1988-10-18 1988-10-18 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (2)

Publication Number Publication Date
DK514989D0 DK514989D0 (da) 1989-10-17
DK514989A true DK514989A (da) 1990-04-19

Family

ID=22208957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK514989A DK514989A (da) 1988-10-18 1989-10-17 Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler

Country Status (33)

Country Link
US (1) US5118703A (da)
JP (1) JPH07597B2 (da)
KR (1) KR910007237B1 (da)
CN (1) CN1022241C (da)
AP (1) AP118A (da)
AR (1) AR246519A1 (da)
AT (1) ATE125794T1 (da)
AU (1) AU606819B2 (da)
BG (1) BG50834A3 (da)
CA (1) CA1339558C (da)
CZ (1) CZ278983B6 (da)
DD (1) DD285604A5 (da)
DK (1) DK514989A (da)
EG (1) EG19887A (da)
FI (1) FI95253C (da)
HU (1) HU208421B (da)
IE (1) IE66586B1 (da)
IL (1) IL91960A (da)
IS (1) IS1598B (da)
MA (1) MA21657A1 (da)
MX (1) MX18021A (da)
MY (1) MY104238A (da)
NO (1) NO178027C (da)
NZ (1) NZ231044A (da)
OA (1) OA09140A (da)
PH (1) PH27554A (da)
PL (2) PL162316B1 (da)
PT (1) PT92000B (da)
RO (1) RO109195B1 (da)
RU (1) RU2036905C1 (da)
SK (1) SK278175B6 (da)
WO (1) WO1990004393A1 (da)
YU (1) YU48070B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5648502A (en) * 1992-11-23 1997-07-15 Pfizer Inc. Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
WO1994018194A1 (en) * 1993-02-09 1994-08-18 Pfizer Inc. Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
CN1094819C (zh) * 1997-04-30 2002-11-27 大兴株式会社 环状坯料之制造装置
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
EP1223809A4 (en) * 1999-10-26 2004-03-03 Univ Texas Southwestern Med Ct METHODS OF TREATING HAIR LOSS COMPRISING THE ADMINISTRATION OF AN INDOLIN COMPOUND

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL96047C (da) * 1956-06-08
US3564009A (en) * 1966-01-13 1971-02-16 Sumitomo Chemical Co Process for producing 1-acylindole derivatives
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3923996A (en) * 1972-07-31 1975-12-02 Sandoz Ag 3-Substituted-oxindoles in compositions and methods of treating obesity
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
DE3268971D1 (en) * 1981-10-06 1986-03-20 Ici Plc Biochemical process
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
ES2075055T3 (es) * 1988-10-18 1995-10-01 Pfizer Profarmacos de 3-acil-2-oxindol-1-carboxamidas antiinflamatorias.
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
SK590689A3 (en) 1996-03-06
CZ590689A3 (en) 1994-04-13
AP118A (en) 1991-02-22
BG50834A3 (en) 1992-11-16
NO178027C (no) 1996-01-10
US5118703A (en) 1992-06-02
FI95253B (fi) 1995-09-29
EG19887A (en) 1996-03-31
PL163112B1 (pl) 1994-02-28
HU208421B (en) 1993-10-28
HUT58052A (en) 1992-01-28
CN1041938A (zh) 1990-05-09
DD285604A5 (de) 1990-12-19
KR910007237B1 (ko) 1991-09-24
SK278175B6 (en) 1996-03-06
AU606819B2 (en) 1991-02-14
WO1990004393A1 (en) 1990-05-03
MX18021A (es) 1993-11-01
AR246519A1 (es) 1994-08-31
AU4295689A (en) 1990-04-26
NO911512L (no) 1991-06-12
YU200589A (en) 1991-02-28
CZ278983B6 (en) 1994-11-16
RO109195B1 (ro) 1994-12-30
IE66586B1 (en) 1996-01-24
IE893332L (en) 1990-04-18
IL91960A (en) 1994-04-12
PL162316B1 (pl) 1993-09-30
CA1339558C (en) 1997-11-25
AP8900141A0 (en) 1989-10-31
IS3509A7 (is) 1990-04-19
JPH07597B2 (ja) 1995-01-11
IL91960A0 (en) 1990-07-12
FI911855A0 (fi) 1991-04-17
YU48070B (sh) 1997-01-08
PT92000A (pt) 1990-04-30
KR900006285A (ko) 1990-05-07
PT92000B (pt) 1995-06-30
DK514989D0 (da) 1989-10-17
NZ231044A (en) 1990-12-21
ATE125794T1 (de) 1995-08-15
IS1598B (is) 1996-05-20
RU2036905C1 (ru) 1995-06-09
OA09140A (fr) 1991-10-31
CN1022241C (zh) 1993-09-29
MA21657A1 (fr) 1990-07-01
MY104238A (en) 1994-02-28
NO911512D0 (no) 1991-04-17
PH27554A (en) 1993-08-18
HU886740D0 (en) 1991-07-29
JPH02149559A (ja) 1990-06-08
NO178027B (no) 1995-10-02
FI95253C (fi) 1996-01-10

Similar Documents

Publication Publication Date Title
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK51493A (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK495585D0 (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
DK189581A (da) Hidtil ukendte heparinestere der er anvendelige til fremstilling af laegemidler og fremgangsmaader til deres frmstilling
DK118791A (da) 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner, deres fremstilling og anvendelse som eller til fremstilling af laegemidler
DK288785D0 (da) Benzensulfonamido-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling af saadanne derivater
DK546788D0 (da) Fremgangsmaade og anordning ti oparbejdning af flyveaske
DK535687D0 (da) Asbestfri friktionsmaterialer og fremgangsmaade til deres fremstilling
DK299089D0 (da) Anvendelse af prostaglandiner til fremstilling af laegemidler
DK537685D0 (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK408786D0 (da) Fremgangsmaade til fremstilling af vitaminforstadier og vitaminer
DK514989A (da) Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler
DK154382A (da) Hidtil ukendte derivater af 2-piperazinopyrimidin,fremgangsmaader til deres fremstilling og deres anvendelse som laegemidlereller mellemprodukter til fremstilling af laegemidler
DK165985C (da) 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler
DK95489A (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
DK221689A (da) Naturstensplade og fremgangsmaade til fremstilling af naturstensplade
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK13989D0 (da) Anvendelse af tnf og lt til fremstilling af laegemidler.
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK170290D0 (da) Fremgangsmaade til fremstilling af vandoploeseligt primycin og dets komponent samt farmaceutiske praeparater indeholdende dem
DK171089D0 (da) Anvendelse af tetrazolderivater til fremstilling af laegemidler
DK68790D0 (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK630089A (da) Anvendelse af aryloxyalkanoler og estere deraf til fremstilling af farmaceutika til behandling af retrovirusinfektioner
DK342287D0 (da) Protein med prokoagulerende virkning,fremgangsmaade til fremstilling af et saadant protein og farmaceutisk praeparat indeholdende proteinet

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment